Dr. Sola Adeleke
Dr. Sola Adeleke is a practicing clinical oncologist working on the NHS frontline. He is the Founder and Chief Executive Officer of Curenetics, a medical technology company harnessing the power of Artificial Intelligence to analyze more data about patients’ cancer genomic profile, imaging data (scans), and medical history.
Using this method helps identify what treatment will be the most effective for each individual patient, tailoring their care and significantly improving the chances of success.
Dr. Sola was inspired to start Curenetics in 2018 because he noticed that the current approach to immunotherapy as a cancer treatment does not deliver the best outcomes for patients.
Read Also: Professor Christopher Imumolen
Although immunotherapy can be very effective, it is expensive, it doesn’t work for everyone, and it can come with significant side effects.
Dr. Sola completed a bachelor’s degree in Medicine and Surgery from Lagos State University, a Master of Business Administration from the University of Lagos, a master’s degree in Oncology and Cancer Biology from the University of Nottingham and a Doctor of Philosophy in Cancer Magnetic Resonance Imaging from the University College, London.
Before Curenetics, Dr. Sola served as an Oncology Registrar at both Sheffield Teaching Hospitals and The Royal Marsden NHS Foundation Trust. He also served as a Clinical Research Fellow in the University College London.
Dr. Sola has assembled a highly skilled team at Curenetics who specialize in using Artificial Intelligence tools to predict patients’ response to cancer therapies. The techniques employed at Curenetics serve as a decision support tool for cancer clinicians and allied medical professionals.